 | | | | Gilead Sciences Inc on Thursday posted higher-than-expected third-quarter earnings as strong demand for its COVID-19 antiviral treatment, Veklury, offset flagging sales of its HIV drugs. | | | | | | The United States has administered 417,795,537 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 510,735,525 doses, the U.S. Centers for Disease Control and Prevention said. | | | | | | White House press secretary Karine Jean-Pierre said on Thursday that the administration will continue working on prescription drug pricing after it did not make it into U.S. President Joe Biden's $1.75 trillion signature spending plan. | | | | | | Britain has reported 39,842 new cases of COVID-19, government data showed on Thursday, meaning cases reported between Oct. 22 and Oct. 28 were down 9.8% compared with the previous seven days. | | | | | | The European Commission has suspended funding to the World Health Organization's programmes in the Democratic Republic of Congo due to concerns over the U.N. agency's handling of the sexual abuse scandal. | | | | | | The Delta coronavirus variant can transmit easily from vaccinated people to their household contacts, a British study found on Thursday, although contacts were less likely to get infected if they were vaccinated themselves. | | | | | | Spanish pharmaceutical group PharmaMar on Thursday said its nine-month net profit slipped 58% to 54.7 million euros ($63.92 million) from a year ago when it booked a hefty gain from a licence payment. | | | | | | Singapore reported 3,432 new cases of COVID-19 on Thursday, a day after recording its highest single-day rise in cases which the city-state's healthy ministry described as an "unusual surge." | | | | | | Spain will ban advertising of unhealthy foods and drinks like chocolate, biscuits and ice cream aimed at children to help fight obesity in young people, the consumer affairs minister said on Thursday. | | | | | | The World Health Organization (WHO) said on Thursday that it was seeking further data from Merck on its experimental new antiviral COVID-19 pill and hoped to issue guidance in coming weeks regarding its use for mild and moderate cases. | | | | | |
